sinilpharm 012790 Algorithm Investment Report

1. Performance Analysis of Algorithm (Separate) 012790 Date
Period 3 months 100-m won
2017.12 2018.12 2019.12 Average 2019.09 2019.12 2020.03 2020.06 2020.09 2020.12
IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep) IFRS(Sep)
Sales 509 533 606 549 156 176 154 150 150 151 159
O-profit 92 60 94 82 20 34 23 23 26 30 25
N-income 82 57 73 71 17 19 20 25 29 33 20
O-rate 18.1 11.3 15.5 14.9 12.8 19.3 14.9 15.3 17.4 19.7 16.6
N-rate 16.1 10.7 12.0 13.0 10.9 10.8 13.0 16.7 19.1 21.9 15.4
ROE 9.0 6.0 7.2 7.4 6.8 7.2 7.3 7.7 7.9 8.2 7.5
Debt-ratio 12.8 11.8 16.4 13.6 14.7 16.4 18.7 17.7 18.5 19.4 17.6
Quick-ratio 413.3 454.1 320.7 396.0 359.1 320.7 283.2 305.7 301.8 302.8 312.2
reserve-ratio 2,200.0 2,305.0 2,457.5 2,320.8 2,412.5 2,457.5 1,776.4 1,821.8 1,645.3 1,486.7 1,933.4
EPS 752 523 670 648 156 174 183 229 264 303 186
BPS 8,338 8,732 9,283 8,784 9,127 9,283 9,365 9,595 9,852 10,116 9,342
Dividends 101 101 109 104
2020-09-03
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ -66 %
High mid ~ -70 %
Mid ~ -74 %
Low mid ~ -78 %
Low price ~ -82 %
Normal
8,096 W 8,096 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 44 3,119 488
13,354 W 13,354 W 11,601 W
11,601 W 11,601 W 9,849 W Evaluation
15,107 W 15,107 W~ 13,354 W
44,600 W
49.29,849 W 9,849 W 8,096 W
High price
Indication price Range Current stock price Company score
8,096원
9,849원
11,601원
13,354원
15,107원
High price 44,600원
-82%
-78%
-74%
-70%
-66%
-90%
-80%
-70%
-60%
-50%
-40%
-30%
-20%
-10%
0.%
0W
5,000W
10,000W
15,000W
20,000W
25,000W
30,000W
35,000W
40,000W
45,000W
50,000W
Low price Low mid Mid High mid High price
Indication price chart (Separate)
Indication price
sinilpharm
Gap
sinilpharm

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (Separate) 012790 Date
Period
Gap
(Indication /
stock)
Color
low price 8,096 W 8,096 W ~ 0 W -82 % 1,146,778 W 142
Low mid 9,849 W 9,849 W ~ 8,096 W -78 % 1,091,718 W 111
Mid 11,601 W 11,601 W ~ 9,849 W -74 % 1,036,657 W 89
High mid 13,354 W 13,354 W ~ 11,601 W -70 % 981,597 W 74
Suggested Purchase
Amount 1,401,110 W
Number of stocks
purchased 31
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 15,107 W 15,107 W~ ~ 13,354 W -66 % 926,537 W 61
2020-09-03
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
44,600 W High price 52.3 Normal 3,800,000 W
Stock price rise
probability score
A Sector 43.9 51.7 45.7 62.8 54.7 44.1
52.3B Sector 12.9 29.0 62.8 62.8 34.6 35.0
Total average 28.4 40.4 37.2 29.2 44.6 39.5
2020.04.08 2020.05.12 2020.06.09 2020.07.07 2020.08.04 2020.09.02
2020.06.09 2020.07.07 2020.08.04 2020.09.02
Total of
increase rate
Total score
A Sector 15 % -13 % 27 % -15 % -24 %
3 % 51.0B Sector 55 % -1 % 54 % -82 % 1 %
Total average 30 % -8 % -28 % 35 % -13 %
2020.05.12
15%
-13%
27%
-15%
-24%
55%
-1%
54%
-82%
1%
30%
-8%
-28%
35%
-13%
-100%
-80%
-60%
-40%
-20%
0%
20%
40%
60%
80%
2020.05.12 2020.06.09 2020.07.07 2020.08.04 2020.09.02
Increase rate of stock price rise
A sector
B sector
Total average
sinilpharm
44
52
46
63
55
44
13
29 29
63
35 35
28
40
37
29
45
40
0
10
20
30
40
50
60
70
2020.04.08 2020.05.12 2020.06.09 2020.07.07 2020.08.04 2020.09.02
Stock price rise probability score
A sector
B sector
Total average

3. may
ded by
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374